Nutex Health IncNUTX
Price$212.31Intrinsic value$782.57269% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $782.57median of 6 methods · middle span $139-$3,032based on filings through 30 Jun 2026
Market Price $212.31Price as of 1 Oct 2026
Margin of Safety +268.6%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 3.5% (near-term consensus, capped) · years 2–5: 43.2%/yr (balance of the path).34.2% per year
Years 6–10: glide to demonstrated growth own history 125.4%, capped at 20%
Per-year rates
Yr 638.6%Yr 733.9%Yr 829.3%Yr 924.6%Yr 1020.0%
43.2% → 20.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 1118.3%Yr 1216.6%Yr 1314.9%Yr 1413.2%Yr 1511.5%Yr 169.8%Yr 178.1%Yr 186.4%Yr 194.7%Yr 203.0%
20.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 1 window (5y) (limited history)125.4%
Discount rate (cost of equity) 12.3%
Volatility vs market (adjusted beta)1.63

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetNutex Health IncNUTXHealth Care
Valuation
P/E8.2×
P/S1.7×
P/B4.1×
EV / Revenue1.5×
EV / EBITDA—
Profitability
Gross margin42.4%
Operating margin37.5%
Net margin21.3%
FCF margin32.4%
Returns
ROE45.6%
ROA18.7%
ROIC78.7%
Growth
Revenue growth (YoY)76.4%
5-yr fwd EPS growth34.2%
Financial strength
Debt / Equity0.10×
Current ratio5.00×
Altman Z-Score4.3
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.